Awareness and utilization of pre-exposure prophylaxis and HIV prevention services among transgender and non-binary adolescent and young adults.
Autor: | Rodriguez A; Department of Medicine, University of California San Diego, La Jolla, CA, United States., Horvath KJ; Department of Psychology, San Diego State University, San Diego, CA, United States., Dowshen N; Craig-Dalsimer Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Voss R; Division of Adolescent Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States., Warus J; Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, CA, United States., Jacobs M; Department of Pediatrics, Oregon Health and Science University, Portland, OR, United States., Kidd KM; Division of Adolescent Medicine, WVU Medicine Children's, Morgantown, WV, United States., Inwards-Breland DJ; Department of Pediatrics, Rady Children's Hospital, UCSD, La Jolla, CA, United States., Blumenthal J; Department of Medicine, University of California San Diego, La Jolla, CA, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in reproductive health [Front Reprod Health] 2024 Jan 22; Vol. 5, pp. 1150370. Date of Electronic Publication: 2024 Jan 22 (Print Publication: 2023). |
DOI: | 10.3389/frph.2023.1150370 |
Abstrakt: | Introduction: Transgender and gender non-binary (TGNB) individuals are disproportionally affected by HIV and face high rates of discrimination and stigmatization, resulting in limited access to HIV prevention services. Pre-exposure prophylaxis (PrEP) is highly efficacious for reducing the risk of HIV transmission. However, little research is available regarding PrEP awareness and utilization among TGNB adolescents and young adults (AYA). Methods: TGNB AYA ages 15-24 years old were recruited between December 2021 and November 2022 for participation in a one-time, anonymous online survey study to assess PrEP awareness and perceptions, as well as barriers to its use. Participants were recruited from seven academic centers offering gender-affirming care to TGNB AYA across the United States. Results: Of the 156 TGNB AYA individuals who completed the survey, most (67%) were aware of PrEP; however, few (7%) had been prescribed PrEP. Many (60%) had not spoken to a medical provider and, even if the medication was free and obtained confidentially, most participants did not plan to take PrEP due to low perceived HIV risk, lack of PrEP knowledge, and concern about interactions between their hormone therapy and PrEP. Discussion: These findings underscore the need for broad PrEP educational efforts for both TGNB AYA and their providers to improve knowledge, identify potential PrEP candidates among TGNB AYA and improve access by addressing identified barriers. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer OVG declared a past co-authorship with the author JB to the handling editor. (© 2024 Rodriguez, Horvath, Dowshen, Voss, Warus, Jacobs, Kidd, Inwards-Breland and Blumenthal.) |
Databáze: | MEDLINE |
Externí odkaz: |